Peptide-Based Nanoparticle for Tumor Therapy
Cancer treatment continues to face significant challenges due to the limitations of conventional therapies, including non-specific toxicity, poor bioavailability, and drug resistance. Nanotechnology, particularly peptide-based nanoparticles (NPs), is increasingly recognized as a valuable strategy to...
Saved in:
| Main Authors: | Phonpilas Thongpon, Menghuan Tang, Zhaoqing Cong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/6/1415 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preparation and Therapeutic Evaluation of Engineered Semaglutide and Statin–Lipid Conjugate-Based Nanoparticle
by: Kyeong-Ju Lee, et al.
Published: (2025-04-01) -
Evaluation of the parameters affecting the loading of anticancer drug Paclitaxel on coated gold nanoparticles for breast cancer treatment
by: Afrooz kharazmi, et al.
Published: (2023-05-01) -
Transformable self-assembling peptide nanoplatforms with tumor microenvironment responsiveness for tumor stem cell suppression and immunomodulation
by: Chen Wei, et al.
Published: (2025-08-01) -
Advances in clinical application of nanoparticle-based therapy for cancer treatment: A systematic review
by: Pingchuan Ma, et al.
Published: (2024-12-01) -
Inherently anti-metastatic peptide hydrogels for sonodynamic-amplified ferroptosis in cancer therapy
by: Hongxia Zhang, et al.
Published: (2025-06-01)